JENNIFER ASHLEY: Open Payments
NPI 1174243943 · RINGGOLD, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$220 in 12 payments from 7 companies in 2025. Trend: 2023 $971 · 2024 $462 · 2025 $220
Food & beverage: $220
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $61 |
| Novo Nordisk Inc | 3 | $58 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| ABBVIE INC. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: Wegovy, MOUNJARO, REXULTI, Auvelity, VRAYLAR, CAPLYTA, ZEPBOUND, TRELEGY ELLIPTA.
Industry payments across GA — which companies pay providers there.
